Pfizer
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $17,702,000 | $13,283,000 | $14,879,000 | $14,249,000 |
Gross Profit | 11,127,000 | 8,243,000 | 10,498,000 | 5,657,000 |
EBITDA | 7,253,000 | 2,405,000 | 5,948,000 | -1,771,000 |
EBIT | 5,498,000 | 674,000 | 4,212,000 | -3,441,000 |
Net Income | 4,465,000 | 24,000 | 3,115,000 | -3,344,000 |
Net Change In Cash | 17,702,000 | 13,283,000 | 14,879,000 | 14,249,000 |
Free Cash Flow | 6,063,000 | -2,419,000 | 387,000 | 4,196,000 |
Cash | 1,092,000 | 1,052,000 | 719,000 | 2,853,000 |
Basic Shares | 5,705,000 | 5,696,000 | 5,697,000 | 5,647,000 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $58,496,000 | $100,330,000 | $81,288,000 | $41,908,000 |
Gross Profit | 28,809,000 | 65,986,000 | 50,467,000 | 33,216,000 |
EBITDA | 9,557,000 | 41,031,000 | 30,793,000 | 13,168,000 |
EBIT | 3,267,000 | 35,967,000 | 25,602,000 | 8,487,000 |
Net Income | 2,119,000 | 31,372,000 | 21,979,000 | 7,020,000 |
Net Change In Cash | 58,496,000 | 100,330,000 | 81,288,000 | 41,908,000 |
Cost of Revenue | -1,350,000 | 218,000 | 483,000 | |
Free Cash Flow | 4,793,000 | 26,031,000 | 29,869,000 | 11,612,000 |
Cash | 2,853,000 | 416,000 | 1,944,000 | 1,784,000 |
Basic Shares | 5,709,000 | 5,733,000 | 5,708,000 | 5,632,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $1.06 |
2024-06-30 | $0.60 |
2024-03-31 | $0.82 |
2023-12-31 | $0.10 |
